Abstract
Defects in cellular immunocompetence have been sought in 25 patients with Kaposi's sarcoma. Skin tests with recall antigens, and PHA lymphocyte stimulation in vitro showed that efferent delayed hypersensitivity responses are intact in the majority. However, attempted sensitization and subsequent challenge with DNCB demonstrated that the afferent limb of the responses was impaired in some patients. This did not appear to be related to the morphology of the tumour or to prognosis.
Tumour specific reactions were demonstrated both in vivo and in vitro and these correlated significantly with the morphology and histology. The interpretation of the results for an individual is confounded by the multiplicity of factors influencing the outcome in a particular patient.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Taylor, J., Ziegler, J. Delayed Cutaneous Hypersensitivity Reactions in Patients With Kaposi's Sarcoma. Br J Cancer 30, 312–318 (1974). https://doi.org/10.1038/bjc.1974.198
Issue Date:
DOI: https://doi.org/10.1038/bjc.1974.198
This article is cited by
-
Kutan-noduläres Kaposi-Sarkom nach Nierentransplantation und Immunsuppression
Klinische Wochenschrift (1984)
-
Neurological complications of Kaposi's sarcomat
Journal of Neuro-Oncology (1983)
